The litigation targets CEO Abel Avellan and CFO Andrew M. Johnson, alleging they misled shareholders between March 4, 2025, and July 15, 2026. The complaint centers on Sarbanes-Oxley certifications that claimed the company held sufficient cash to meet capital requirements for twelve months, even as the firm pursued significant convertible note offerings. According to the filing, these executives offloaded more than $18 million in company stock during the same period.

The market reacted sharply to the company's disclosure of a third $1 billion convertible note offering on July 15, 2026. Shares of ASTS plummeted 17.04% the following day, closing at $55.01 per share. Attorney Joseph E. Levi, representing the plaintiffs, contends that the executives breached their duty to provide accurate public disclosures regarding the company's financial durability. Investors who purchased shares during the specified class period may be eligible to participate in the recovery process, which is being handled on a contingency basis.